Strategies and Practices in Off-Label Marketing of Pharmaceuticals: A Retrospective Analysis of Whistleblower Complaints

Whistleblower-Initiated Enforcement Actions against Health Care Fraud and Abuse in the United States, 1996 to 2005

(2013) Aaron S. Kesselheim et al.   ANNALS OF INTERNAL MEDICINE

The ADVANTAGE Seeding Trial: A Review of Internal Documents

(2013) Kevin P. Hill et al.   ANNALS OF INTERNAL MEDICINE

Whistle-Blowers' Experiences in Fraud Litigation against Pharmaceutical Companies

(2010) Aaron S. Kesselheim et al.   NEW ENGLAND JOURNAL OF MEDICINE

Toward More Uniform Conflict Disclosures — The Updated ICMJE Conflict of Interest Reporting Form

(2010) Jeffrey M. Drazen et al.   NEW ENGLAND JOURNAL OF MEDICINE

Shifting Terrain in the Regulation of Off-Label Promotion of Pharmaceuticals

(2009) Michelle M. Mello et al.   NEW ENGLAND JOURNAL OF MEDICINE

The promotion of olanzapine in primary care: An examination of internal industry documents

(2009) Glen I. Spielmans   SOCIAL SCIENCE & MEDICINE

FDA Guidance on Off-Label Promotion and the State of the Literature From Sponsors

(2008) Bruce M. Psaty   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Guest Authorship and Ghostwriting in Publications Related to Rofecoxib

(2008) Joseph S. Ross et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Pharmaceutical Promotion to Physicians and First Amendment Rights

(2008) Aaron S. Kesselheim et al.   NEW ENGLAND JOURNAL OF MEDICINE

Off-Label Promotion, On-Target Sales

(2008) Adriane Fugh-Berman et al.   PLOS MEDICINE